The biopharmaceutical industry creates over 30,000 direct jobs in Ireland, with about as many more supported in spin-off employment. The medicines we make treat some of the world’s most complex diseases, improving, prolonging and, sometimes, saving lives. Our economic, social and human impact counts. It matters to patients and their families, to the people who work in our companies, and to the communities across the regions that benefit from the presence large-scale multinational investments.
On 3 and 4 March 2020, we will mark that impact, as well as looking to the future for the industry, at a major event in The Printworks, Dublin Castle.
BioPharma Ambition is a stage to celebrate the discovery, development, manufacture and delivery of innovative medicines and technologies for improving human health. The event is led by the industry’s representative bodies, IPHA and BPCI, and the National Institute for Bioprocessing Research and Training (NIBRT). It was held before in 2016 and 2018 at the same venue. Then, we drew more than 800 delegates from across the island of Ireland and from around the world - experts in industry, policy, research, academia, clinical care, entrepreneurship and finance. This year, we will bring even more global influencers to Dublin, strengthening our networks, research collaborations, reputation and investment proposition as we look to the future of innovation in biopharmaceutical research and manufacturing.
BioPharma Ambition aims to position Ireland as a globally networked player in biopharmaceutical innovation. The event, outward-facing and future-orientated, will help to build our reputation as a consequential investor, as a responsible innovator and as a global connector. It will enable the seeding of a new set of perceptions about the value of innovation and our industry’s role in improving Ireland’s society and economy. Our dedication to the application of science for new therapies and cures is exciting.
BioPharma Ambition 2020 will capture that excitement. The event will mine new frontiers in presentation, content, contributors and communications. The programme is still in development and it is shaping up well. It will be a blend of workshops, keynotes, thematic presentations and moderated discussions. All of these will explore the themes shaping our industry, including public-private partnerships, next-generation therapies, factory 4.0 and connected health. Among the keynoters are Professor Ian Greer, President and Vice-Chancellor, Queen's University Belfast and James C. Greenwood, President and CEO of the Biotechnology Innovation Organisation, and former US Congressman. The Taoiseach, Leo Varadkar TD, has been invited to open the event. NIBRT and PwC will hold special workshops on 3 March. The Government will host special guests at Iveagh House in Dublin while, at the Mansion House, we will host a dinner for conference delegates.